Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube
    Latest

    Venous News

    Endovenous laser therapy of saphenous vein reflux using thulium laser with...

    Intravascular ultrasound in venous disease

    The success of deep venous intervention rests on mid- to long-term...

    BTG launch Varithena in Canada

    VeClose trial indicates 24-month non-inferiority of VenaSeal versus radiofrequency ablation

    mechanochemical ablation

    MOCA effective for greater saphenous vein insufficiency out to three years

    cyanoacrylate adhesive perforator embolisation

    Cyanoacrylate adhesive perforator embolisation successful while avoiding risk of “inadvertent thermal...

    US FDA grants 510(k) clearance to Teleflex for Arrow VPS Rhythm...

    Final patient enrolled for iliofemoral venous stent study

    biolitec introduces new Leonardo Mini multi-function laser

    Assessing the outcomes of venous interventions

    Venography and IVUS for the diagnosis and treatment of iliofemoral venous...

    IVUS may be a more accurate method than venography for assessing...

    Two new real-world studies confirm positive efficacy and safety profile of...

    Treatment of superficial vein thrombosis with intermediate doses of tinzaparin

    Lymphoedema management: A collaborative approach for patients and clinicians

    Endothermal heat-induced thrombosis after endovenous laser ablation—a rare complication with safe...

    Veniti closes on US$25m from Boston Scientific

    Ultrasound-enhanced catheter-directed thrombolysis as the standard of care for acute DVT

    CE mark granted to FlowAid Medical FA100 sequential contraction compression device

    Varithena earns FDA approval for 30-day post-activation shelf life

    Key clinical questions I would like to see answered in the...

    VenaSeal closure system demonstrates long-term durability and improved quality of life...

    “IVUS should be the gold standard for diagnosing and directing treatment...

    Early data from venous stent trials “very promising”

    Non-thrombotic iliac vein lesions trigger “paradigm shift”

    EVRF system trial shows 96.8% complete occlusion at three years

    Hybrid operative thrombectomy is non-inferior to percutaneous techniques for acute iliofemoral...

    Authorisation and reimbursement for radiofrequency and endovenous laser ablation across Europe

    A novel method of oedema fluid drainage in obstructive lymphoedema

    Saphenous pulsation on duplex ultrasound is a marker of severe chronic...

    AMPLIFY data indicate Eliquis (apixaban) is comparable to conventional therapy in...

    Lawrence Livermore National Lab and Near Infrared Imaging release Vein-Eye camera

    Dedicated endovenous stents effective to relieve outflow obstruction at one year

    NICE recommends once-daily Lixiana (edoxaban) to treat and prevent adult recurrent...

    Real world ETNA registries of new once-daily edoxaban commence in Europe

    Cancer-associated thrombosis patients 35% less likely to experience thromboembolism when treated...

    Health Canada approves polidocanol injectable foam for patients with varicose veins

    NICE publishes final guidance on the use of Eliquis (apixaban) to...

    A record-breaking week for the CX Venous Workshop

    CX Venous Workshop draws in the crowds

    Edoxaban approved for prevention of stroke and systemic embolism in non-valvular...

    Preliminary data suggest VenaTech convertible filter is a safe and effective...

    Intrinsic Imaging awarded interventional medical device trial for prevention of pulmonary...

    New varicose vein treatment available in Europe

    FDA classifies Covidien field action for Trellis-6 and Trellis-8 systems as...

    FDA approves Savaysa for reduction of stroke risk in non-valvular atrial...

    Secondary analysis of AMPLIFY-EXT examining predictors of hospitalisation presented at ESC...

    Is all heat the same and does catheter design matter?

    First varicose vein patient treated with FDA-approved Varithena (polidocanol injectable foam)...

    European Commission approves Eliquis (apixaban) for treatment of deep vein thrombosis...

    More bleeding with catheter-directed thrombolysis than with standard anticoagulation in deep...

    FDA IDE approval for Veniti Vici venous stent system

    Multicentre study evaluates method to improve retrieval rate of inferior vena...

    Covidien launches next generation Trellis peripheral infusion system

    Eliquis (apixaban) receives CHMP positive opinion for the treatment of deep...

    EKOS initiates study in patients with chronic deep vein thrombosis and...

    Pradaxa gains EU approval

    Cook Medical begins two studies on inferior vena cava filters

    Pelvic vein reflux could cause haemorrhoids, study suggests

    Evidence for deep venous reconstruction is “extremely weak”

    FDA approves Pradaxa for treatment of deep venous thrombosis and pulmonary...

    Delegates benefit from hands-on training and learning at the CX Office-based...

    Edoxaban evaluated in two subgroup analyses of East Asian patients from...

    For the first time, Charing Cross hosts three days of venous...

    Veniti announces first uses of Veniti Vici Venous Stent System

    ULTIMA trial results published in Circulation

    Option Elite retrievable vena cava filter receives FDA clearance for a...

    Sapheon submits second module of PMA application for VenaSeal Sapheon Closure...

    New drug application for edoxaban submitted in Japan

    Phase III study of dabigatran meets primary endpoint for six-month treatment...

    FDA approves polidocanol injectable foam for varicose veins

    New rotational pharmacomechanical thrombectomy device promising for deep vein thrombosis

    Treating cutaneous ulcers with human skin wound dressings

    Screening can significantly reduce number of venous thromboembolism deaths

    LeMaitre Vascular acquires InaVein

    New anticoagulant edoxaban shows less bleeding than warfarin in Hokusai-VTE

    Sapheon completes enrolment in US pivotal study of VenaSeal

    Tactile Medical launches wound care product to treat venous leg ulcers

    Canadian study suggests no link between venous stenosis and multiple sclerosis

    Thermocoagulation of the great saphenous vein with EVRF is safe and...

    Offer less invasive treatments before surgery for varicose veins, says UK...

    No evidence to support placement of filters in patients undergoing bariatric...

    New segmental venous stent shows superior patency rates in occlusive disease

    Glue is a promising tool in the varicose vein occlusion armamentarium

    NICE UK draft guidance recommends rivaroxaban for pulmonary embolism

    Global clinical study initiated to determine safety and effectiveness of stent...

    Ultrasound-accelerated thrombolysis shows advantage over anticoagulation alone in submassive pulmonary embolism

    Studies support benefit of dabigatran for prevention of recurrent deep vein...

    ALN launches Vena Cava Filter with Hook in the USA

    PREFER in VTE European registry enrols first patient

    PEARL registry results suggest rheolytic thrombectomy combined with adjunctive therapy is...

    Five-year results from the ClosureFast long-term European multicentre study announced

    Volcano Corporation to acquire Crux Biomedical

    European commission approves rivaroxaban for the treatment of pulmonary embolism and...

    ASPIRE trial shows 34% reduction in major vascular events with aspirin...

    FDA expands use of rivaroxaban to treat deep vein thrombosis or...

    Rivaroxaban recommended for approval for pulmonary embolism in Europe

    Computerised checklist offers best preventive strategy for venous thromboembolism

    Cook Medical launches Zilver Vena Venous Self-Expanding Stent in Canada

    UK’s NICE consults on new draft quality standard for management of...

    Vascular Insights announces randomised clinical trial comparing VNUS Closure Fast with...

    Phase III study investigates cell-based therapy for venous leg ulcers

    New developments in retrievable inferior vena cava filters reviewed

    94% closure rate of varicose veins after one year with VenaSeal...

    Radiofrequency ablation effective in the treatment of large diameter varicose veins...

    Study based on “real world” US database sheds light on inferior...

    Tulip fibre shows reduced side-effects in great saphenous vein ablation

    FDA clears first ever bi-directionally retrievable vena cava filter from Crux...

    Ultrasound-accelerated catheter-directed thrombolysis of acute iliofemoral vein thrombosis remains safe

    FDA grants priority review for rivaroxaban supplemental new drug application for...

    Covidien launches campaign to increase awareness of pregnancy-related blood clots

    NICE clinical guideline set to save lives by improving the diagnosis...

    Mechanochemical ablation shows 96% closure rate at two years

    Angel Catheter is CE-marked

    Satisfactory results with endovenous laser ablation 6.5 years after treatment

    Stryker launches Restep deep vein thrombosis compression sleeve

    UK’s NICE encourages research on percutaneous venoplasty for multiple sclerosis

    Rivaroxaban shows comparable efficacy to standard of care for pulmonary embolism...

    Percutaneous endovenous intervention effective for upper extremity deep venous thrombosis

    Recurrence after ablation for varicose veins associated with perforating veins

    Long-term outcomes of percutaneous mechanical thrombectomy for severe pulmonary embolism

    FDA clears NeverTouch Direct Procedure Kit to treat varicose veins

    Scottish Medicines Consortium accepts rivaroxaban for NHS use in two new...

    Vascular Solutions launches reprocessing service for ClosureFAST catheter

    Crux Biomedical’s inferior vena cava filter receives CE mark

    One-year data of the Sapheon Closure system trial show positive results

    Catheter-directed thrombolysis reduces risk of post-thrombotic syndrome in patients with DVT...

    Bluegrass Vascular Technologies begins first clinical study of the Surfacer Inside-Out...

    Edoxaban significantly reduces risk of venous thromboembolism by half compared to...

    Bioconvertible inferior vena cava filter could eliminate retrieval and complications

    Load more

    Most read

    Features

    Profiles

    Ramon Varcoe

    Kevin Mani

    Bijan Modarai

    Vascular News

    Write to us
    Editor: Jocelyn Hudson [email protected]
    Advertising: Rav Pankhania [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter Youtube